Centre for Law, Medicine and Life Sciences (LML) Podcast

Faculty of Law, University of Cambridge
Centre for Law, Medicine and Life Sciences (LML) Podcast

The Cambridge Centre for Law, Medicine and Life Sciences (LML), led by Dr Kathleen Liddell (Director) and Dr Jeffrey Skopek (Deputy Director), advances research and teaching on legal and ethical challenges at the forefront of medicine and the life sciences. Rapid and prolific scientific advances, alongside changing attitudes towards health, medical care, family structures and related issues, pose some of the most difficult research questions of our era. These include questions about the adequacy of patents to incentivize medical innovation, the nature of informed consent, the allocation of liability for medical wrongs, the scope of privacy rights in electronic health records, the rationing of medical care, the regulation of emerging technologies and the implications of personalized medicine. In addressing these and many other challenges, LML looks beyond the boundaries of medical law as traditionally conceived. Our members specialise not only in medical law and bioethics, but also in areas such as competition law, family law, human rights, public law, information law, international law and intellectual property. In addition, many have training in disciplines other than law (including medicine, economics, history and philosophy) and relevant professional experience (including legal practice, private consultancy and civil service). This playlist contains lectures and other events held by the LML. For more information see the LML website: at http://www.lml.law.cam.ac.uk/

  1. 21 MAR

    Repugnant transactions and taboo trades: The Baron de Lancey Lecture 2025

    Professor Kimberly D. Krawiec from the University of Virginia School of Law explores "repugnant transactions and taboo trades" — markets that are morally contested and sometimes even prohibited, such as sex work, commercial surrogacy, and the sale of organs, eggs, and sperm. She asks how we, as a society, decide what is up for sale and what is off-limits. The controversies here are not about the dangers of markets themselves, but rather the dangers of buying/selling certain goods or services. Advocates of market restrictions seek to define the ethical boundaries of the marketplace – to identify the specific goods and services that are inappropriate for market trading, and to explain why these restrictions should exist even for apparently willing buyers and sellers. Although all cultures have deemed some transactions too sacred for the marketplace, the targets of these restrictions have varied widely, even within a given time period. For example, prostitution is currently legal in much of the world but illegal in most of the United States. Meanwhile, commercial surrogacy and paid egg donation are legal in much of the United States but illegal in many other parts of the world. This talk delves into these and other restricted trades. It identifies how they are regulated by legal regimes as well as social norms, evaluates the consequences of different approaches, and explores potential paths forward. About the Speaker: Professor Kimberly D. Krawiec holds the Charles O. Gregory Professorship of Law at the University of Virginia. Her current research analyses “taboo trades” — exchanges that are contested by society and, in some cases, forbidden altogether. She has written on commercial surrogacy, egg and sperm markets, and sex work. At the moment, much of her work is on incentives for organ donation. Another area of her research centres on the regulation of financial markets and business organizations. Prof. Krawiec has extensively examined the administrative process surrounding the Volcker Rule, a complex and highly contested provision of the Dodd-Frank Act. She has also researched corporate boards of directors. Through an ethnographic method, this work analyses directors’ views on the workings of the corporate boardroom and board relations with management, with a special emphasis on directors’ views on race and gender diversity in the boardroom. With a wealth of experience in commodity and derivatives law, she has also been a commentator for the Central European and Eurasian Law Initiative (CEELI) of the American Bar Association and has taught at top institutions including Duke, North Carolina, Harvard, and Northwestern, where she won the Robert Childres Award for Teaching Excellence. The lecture begins at 03:44 Baron Cornelius Ver Heyden de Lancey (1889-1984) was a wealthy and public-spirited Dutchman who at different times in his life was a dentist, doctor, surgeon, barrister and art historian. In 1970 he created the De Lancey and De La Hanty Foundation, to promote studies in medico-legal topics. The Foundation generously gave Cambridge the Ver Heyden de Lancey Fund, which since 1996 has funded occasional public lectures on medico-legal issues of current interest. For more information about the Baron Ver Heyden de Lancey Lecture series, please see http://www.lml.law.cam.ac.uk/events/vhdl-events

    43 min
  2. 15/03/2022

    Re-engineering the Regulation of Regenerative Medicine?: The 2022 Baron de Lancey Lecture

    Regenerative medicine seeks to regrow, repair, or replace damaged tissues. Current regenerative technologies include the bio-engineering of organs and tissues, cell reprogramming, and gene editing. Such interventions are significant not only for present-day patients, but also for future generations. They challenge the concept of the self as ‘biologically finite’ or ‘genetically determined’ and blur traditional distinctions between therapy and enhancement and between humans, animals, and things. Given the ways in which regenerative medicine blurs socially-significant boundaries, the ethical and legal obligations of clinicians, researchers, funders, and governments are fluid and uncertain. For example, it is unclear whether present policies governing the use of regenerative technologies offer sufficient safeguards, even if access is limited to patients with conditions deemed sufficiently serious to justify the risks. This talk explores whether international human rights law might require governments to identify, monitor, and support translational pathways that would provide broad, equitable access to the benefits of regenerative medicine, or whether international human rights law requires a more controlled approach because of the potential social implications. With regenerative medicine's great potential, the welfare of current and future generations is at stake. We must collectively ask ourselves how best to secure a desirable clinical future for present day and future generations. About the Speaker: Bartha Maria Knoppers is Full Professor, Canada Research Chair in Law and Medicine, and Director of the Centre of Genomics and Policy at McGill University. Baron Cornelius Ver Heyden de Lancey (1889-1984) was a wealthy and public-spirited Dutchman who at different times in his life was a dentist, doctor, surgeon, barrister and art historian. In 1970 he created the De Lancey and De La Hanty Foundation, to promote studies in medico-legal topics. The Foundation generously gave Cambridge the Ver Heyden de Lancey Fund, which since 1996 has funded occasional public lectures on medico-legal issues of current interest. For more information about the Baron Ver Heyden de Lancey Lecture series, please see http://www.lml.law.cam.ac.uk/events/vhdl-events

    59 min
  3. 12/03/2019

    Should parents have the final say on the medical treatment of their children?: The 2019 Baron de Lancey Lecture

    Baron Cornelius Ver Heyden de Lancey (1889-1984) was a wealthy and public-spirited Dutchman who at different times in his life was a dentist, doctor, surgeon, barrister and art historian. In 1970 he created the De Lancey and De La Hanty Foundation, to promote studies in medico-legal topics. The Foundation generously gave Cambridge the Ver Heyden de Lancey Fund, which since 1996 has funded occasional public lectures on medico-legal issues of current interest. The 2019 Baron de Lancey Lecture was delivered by Imogen Goold, Associate Professor in Law at the University of Oxford, on 8 March 2019, and was entitled "Should parents have the final say on the medical treatment of their children?". Imogen Goold is Associate Professor in Law at the University of Oxford, and a Fellow of St Anne's College. She studied Law and Modern History at the University of Tasmania, Australia, receiving her PhD in 2005. Her doctoral research explored the use of property law to regulate human body parts. She also received a Masters degree in Bioethics from the University of Monash in 2005. From 1999, she was a research member of the Centre for Law and Genetics, where she published on surrogacy laws, legal constraints on access to infertility treatments and proprietary rights in human tissue. In 2002, she took up as position as a Legal Officer at the Australian Law Reform Commission, working on the inquiries into Genetic Information Privacy and Gene Patenting. After leaving the ALRC in 2004, she worked briefly at the World Health Organisation, researching the provision of genetic medical services in developing countries. Her research interests include the regulation of IVF, the ownership of human body parts and the impact of artificial intelligence on the law of tort. For more information about the Baron de Lancey Lecture series, please see: http://www.lml.law.cam.ac.uk/events/vhdl-events

    54 min
  4. 12/03/2018

    Parenthood Disrupted(?) Dilemmas of Reproductive Technologies: The Baron Ver Heyden de Lancey Lecture 2018

    Baron Cornelius Ver Heyden de Lancey (1889-1984) was a wealthy and public-spirited Dutchman who at different times in his life was a dentist, doctor, surgeon, barrister and art historian. In 1970 he created the De Lancey and De La Hanty Foundation, to promote studies in medico-legal topics. The Foundation generously gave Cambridge the Ver Heyden de Lancey Fund, which since 1996 has funded occasional public lectures on medico-legal issues of current interest. The 2018 Baron Ver Heyden de Lancey Lecture on Medico-Legal Studies was delivered by Professor Glenn Cohen is a Professor of Law at Harvard University, on 9 March 2018, and was entitled "Parenthood Disrupted(?) Dilemmas of Reproductive Technologies". Glenn Cohen is a Professor of Law at Harvard University, and one of the world's leading experts on the intersection of bioethics and the law. His award-winning research has appeared in the top legal, ethical and medical journals, and he is regularly cited in national news media. He has authored and edited several books, including Patients with Passports, Specimen Science, and Identified versus Statistical Lives. Prior to receiving tenure at Harvard, he served as a law clerk on a U.S. federal Court of Appeals and as an appellate lawyer for the U.S. Department of Justice. In his spare time, he still litigates, most recently having authored amicus briefs for U.S. Supreme Court cases on the patentability of human genes and abortion rights. This event is kindly sponsored by the Ver Heyden de Lancey Fund, and organised by the Centre for Law, Medicine and Life Sciences, in collaboration with Cambridge Family Law. For more information about the Baron Ver Heyden de Lancey Lecture series, please see http://www.lml.law.cam.ac.uk/events/vhdl-events

    58 min

Ratings & Reviews

4.5
out of 5
4 Ratings

About

The Cambridge Centre for Law, Medicine and Life Sciences (LML), led by Dr Kathleen Liddell (Director) and Dr Jeffrey Skopek (Deputy Director), advances research and teaching on legal and ethical challenges at the forefront of medicine and the life sciences. Rapid and prolific scientific advances, alongside changing attitudes towards health, medical care, family structures and related issues, pose some of the most difficult research questions of our era. These include questions about the adequacy of patents to incentivize medical innovation, the nature of informed consent, the allocation of liability for medical wrongs, the scope of privacy rights in electronic health records, the rationing of medical care, the regulation of emerging technologies and the implications of personalized medicine. In addressing these and many other challenges, LML looks beyond the boundaries of medical law as traditionally conceived. Our members specialise not only in medical law and bioethics, but also in areas such as competition law, family law, human rights, public law, information law, international law and intellectual property. In addition, many have training in disciplines other than law (including medicine, economics, history and philosophy) and relevant professional experience (including legal practice, private consultancy and civil service). This playlist contains lectures and other events held by the LML. For more information see the LML website: at http://www.lml.law.cam.ac.uk/

More From Cambridge University

To listen to explicit episodes, sign in.

Stay up to date with this show

Sign in or sign up to follow shows, save episodes and get the latest updates.

Select a country or region

Africa, Middle East, and India

Asia Pacific

Europe

Latin America and the Caribbean

The United States and Canada